Apolipoproteins and their role in different clinical conditions: An overview

Indian Journal of Biochemistry and Biophysics

Volumn 42, Issue 2, 2005, Pages 73-80

  Irshad, M ^a   Dubey, R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoproteins; Clinical implications; Lecithin cholesterol acyl transferase; Lipoprotein lipase; Lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN;

CLINICAL MEDICINE; DISEASES; HUMAN; METABOLISM; SHORT SURVEY;

APOLIPOPROTEINS; CLINICAL MEDICINE; DISEASE; HUMANS;

EID: 28244433804     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (72)

1. Gustafson A, Alaupovic P & Furman R H (1966) Studies of the composition and structure of serum lipoproteins. Separation and characterization of phospholipid-protein residues obtained by partial delipidization of very low density lipoproteins of human serum. Biochemistry 5, 632-40
2. Law S W, Lackner K J, Fojo S S, Hospattankar A, Monge J C & Brewer H B Jr (1986) The molecular biology of human apo A-I, apo A-II, apo C-II, apo B. In Argel A & Frolich J: Lipoprotein deficiency syndromes. Advances in Exp Med and Biology Vol. 201, Plenum Press, New York
3. Montine K S, Bassett C N, Ou J J, Markesbery W R, Swift L L & Montine T J (1998) Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins. J Lipid Res 39, 2443-2451
4. th edn., Chapt 118, pp. 2817-2833, McGraw Hill, London
5. Knott T J, Rall Sc Jr, Innerarity T L, Jacobson S F, Urdea M S, Levy-Wilson B, Powell L M, Pease R J, Eddy R & Nakai H (1985) Human apoprotein B: Structure of carboxyl-terminal domains, sites of gene expression and chromosomal localization. Science 230, 37-43
6. Scott J (1990) RNA editing: a novel mechanism for the regulation of dietary cholesterol absorption. The Humphry Davy Rolleston lecture 1989. J R Coll Physicians Lond 24, 101-106
7. Lusis A J (1988) Genetic factors affecting blood lipoproteins: The candidate gene approach. J Lipid Res 29, 397-429
8. Calvert G D & Abbey M (1985) Plasma lipoproteins and apoproteins and proteins concerned with lipid metabolism. Adv Clin Chem 24, 217-98
9. Schettler V, Monazahian M, Wieland E, Ramadori G, Grunewald R W, Thomssen R & Muller G A (2001) Reduction of hepatitis C virus load by H.E.L.P.-LDL apheresis. Eur J Clin Invest 31, 154-5
10. th edn, Vol. 2, pp.1212, Saunders Publications, Sydney
11. Chen S H, Habib G, Yang C Y, Gu Z W, Lee B R, Weng S A, Silberman S R, Cai S J, Deslypere J P & Rosseneu M (1987) Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 237, 363-366
12. Drayna D T, McLean J W, Wion K L, Trent J M, Drabkin H A & Lawn R M (1987) Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2-u-globulin superfamily: DNA 6, 199-204
13. Navarro A, Tolivia J, Astudillo A & del Valle E (1998). Pattern of apolipoprotein D immunoreactivity in human brain. Neurosci Lett 254, 17-20
14. Hall R E, Aspinall J O, Horsfall D J, Birrell S N, Bentel J M, Sutherland R L & Tilley W D (1996) Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D in human breast cancer. Br J Cancer 74, 1175-80
15. Serra Diaz C, Vizoso F, Lamelas M L, Rodriguez J C, Gonzalez L O, Baltasar A & Medrano J (1999) Expression and clinical significance of apolipoprotein D in male breast cancer and gynaecomastia. Br J Surg 86, 1190-1197
16. Aspinall J O, Bentel J M, Horsfall D J, Haagensen D E, Marshall V R & Tilley W D (1995) Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues. J Urol 154, 622-628
17. Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, Milne R & Rassart E (1998) Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem 71, 1643-1650
18. th edn., Lipid Lipoprotein and Apoprotein, Chapt. 24, pp. 462-492, W.B. Saunders, Sydney
19. Mehdi H, Kaplan M J, Anlar F Y, Yang X, Bayer R, Sutherland K & Peeples M E (1994) Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 68, 2415-24
20. de Silva H V, Stuart W D, Duvic C R, Wetterau J R, Ray M J, Ferguson D G, Albers H W, Smith W R & Harmony J A (1990) A 70-kDa apolipoprotein designated Apo J is a marker for subclasses of human plasma high density lipoproteins. J Biol Chem 265, 13240-13247
21. Uterman G (1989) The mysteries of lipoprotein(a). Science 246, 904-910
22. Nielson L B (1999) Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies to arterial wall influx, degradation and efflux. Atherosclerosis 143, 229-243
23. Karathanasos S N, Ferris E & Haddad I A (1987) DNA inversion within apo A-I, C-II, A-IV encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci USA 84, 7198-7202
24. Norum R A, Lakier J B & Goldstein S (1982) Familial deficiency of apoprotein A-I and C-III and precacious coronary heart disease. N Eng J Med 306, 1513-1519
25. Schaefer E J, Blum C B, Levy R I, Jenkins L L, Alaupovic P, Foster D M & Brewer H B Jr (1978) Metabolism of high density lipoprotein, apoprotein in Tangier disease. N Engl J Med 299, 905-910
26. th edn. Vol. II. pp. 2031-2052, McGrawHill, London
27. Bostom A G, Gagnon D R & Cupple L A (1994) A prospective investigation of elevated liproprotein(a) detected by electrophoresis and cardiovascular disease in women. Circulation 90, 1688-1695
28. Ridker P M, Henne Kens C H & Stampfer M J (1993) A prospective study of lipoprotein (a) and risk of myocardial infarction. J Am Med Assoc 27, 2195-2199
29. Miles L A & Plow E F (1990) Lp (a): an interpolar into the fibrinolytic system. Thromb Haemost 63, 331-335
30. Von Hodenberg E, Kreuzer J & Hautmann M (1990) Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction. Am J Cardiol 67, 1349-1353
31. Linden T, Taddei-peters W & Wilhelmsen L (1999) Serum lipids, lipoprotein (a) and Apo (a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery. Atherosclerosis 137, 175-186
32. Bahl V K, Vaswani M, Thatai D, Wasir H S (1994) Plasma levels of apolipoproteins A-1 and B in Indian patients with angiographically defined coronary artery disease. Int J Cardiol 46, 143-149
33. Dunder K, Lind L, Zethelius B, Berglund L, Lithel H. (2004) Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men. Am Heart J 148, 596-601.
34. Nayak S S, Kamath S S, Kundaje G N & Aroor A R (1988) Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma patients. Clin Chem Acta 173, 157-164
35. Kervinene K, Sodervik H & Makela J (1996) Is the development of adenoma and carcinoma in proximal colon related to Apoprotein E Phenotype? Gastroentrology 110, 1785-1790
36. Vogel T, Guo N H, Guy R, Drezlich N, Krutzsch H C, Blake D A, Panet A & Roberts D D (1994) Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem 54, 299-308
37. Yu H K, Kum J S, Lee H J, Ahn J H, Lee S K, Hong S W & Yoon Y (2004) Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles. Cancer Res 64, 7092-7098
38. Lamelas M L, Vazquez J, Enguita M I, Rodriguez J C, Gonzalez L O, Merino A M & Vizoso F (2000) Apolipoprotein D expression in metastatic lymph nodes of breast cancer. Int J Surg Investig 2, 285-293
39. Hachem H, Favre G, Raynal G, Blavy G, Canal P & Soula G (1986) Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosis. J Clin Chem Clin Biochem 24, 161-166
40. Irshad M (2004) Serum lipoprotein(a) levels in liver diseases caused by hepatitis. Ind J Med Res 120, 542-545
41. Basili S, Andreozzi P, Vieri M, Maurelli M, Cara D, Cordova C & Alessandri C (1997) Lipoprotein (a) serum levels in patients with hepatocarcinoma. Clin Chim Acta 262, 53-60
42. Folin M, Baiguera S, Conconi M T, Di L R, De C E, Parnigo H O I & Nussdorfer G G (2004) Apolipoprotein E as vascular risk factor in neurodegenerative dementia. Int J Mol Med 14, 609-613
43. Ribalta J, Vallve J C, Girona J, Masana L. (2003) Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease. Curr Opin Clin Nutr Metab Care 6, 177-187
44. Rocchi A, Pellegrini S, Siciliano G, Murri L. (2003) Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull 61, 1-24
45. Tycko B, Lee J H, Ciappa A, Saxena A, Li C M, Feng I, Arriaga A, Stern L R, Shachter N & Mayeux R (2004) Apo E and Apo C1 promoter polymorphisms and the risk of Alzheimer disease in African, American and Caribbean Hispanic individuals. Arch Neurol 61, 1434-1439
46. Kay A D, Petzold A, Kerr M, Keir G, Thompson E J & Nicoll J A (2003) Cerebrospinal fluid apolipoprotein E concentration decrease after traumatic brain injury. J Neurotrauma 20, 243-250
47. Leung C H, Poon W S, Yu L M, Wong G K & Ng H K (2002) Apolipoprotein E genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke 33, 548-552
48. Kay A, Petzold A & Kerry M (2003) Decrease cerebrospinal fluid apoprotein E after sub arachnoid haemorrhage. Correlation with injury severity and clinical outcome: Stroke 34, 637-642
49. Mehta P D, Patrick B A, Pirttila T, Coyle P K & Aisen P S (2003) Detection of apolipoprotein E Phenotype in unconcentrated cerebrospinal fluid. J Clin Lab Anal 17, 18-21
50. Erem C, Deger O, Bostan M, Orem A, Sonmez M, Ulusoy S & Telatar M (1999) Plasma lipoprotein (a) Concentration in hypothyroid, euthyroid and hyperthyroid subjects. Acta Cardiol 54, 77-81
51. Sucic M, Bozikov V, Mesic R & Sokolic L (1998) Lipoprotein (a) levels in thyroid dysfunction before and after treatment. Croat Med J 39, 19-22
52. Ozata M, Yildirimkaya M, Yilmaz K, Kutluay T, Corakci A, Beyhan Z & Gundogan M A (1998) The effect of thyroid status on serum apolipoprotein A-1 containing lipoproteins particle: Horn Metals Res 30, 217-221
53. Asami T, Ciomartian T & Uchiyama M (1999) Changes in serum apolipoprotein concentration after L-thyroxine therapy in infants with congenital hypothyroidism. Metabolism 48, 1343-1345
54. Hojbjerg Gravholt C, Christian Klausen I, Weeke J & Sandahl Christiansen J (2000) Lp(a) and lipids in Adult Turner's syndrome. Impact of treatment with 17-beta-estradiol and norethisterone. Atherosclerosis 150, 201-208
55. Attman P O, Samuelsson O & Alaupovic P (1997) Progression of renal failure: role of apolipoprotein B-containing lipoproteins. Kidney Int Suppl 63, S98-101
56. Batista M C, Welty F K, Diffenderfer M R, Sarnak M J, Schaefer E J, Lam Fava S, Asztalos B F, Dolnikowski G G, Brausseau M E & Marsh J B (2004) Apolipoprotein A-I, B-100 and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome. Metabolism 53, 1255-1261
57. Wanner C & Quaschning T (2001) Dyslipidemia and renal disease: pathogenesis and clinical consequences. Curr Opin Nephrol Hypertens 10, 195-201
58. Barbagallo C M, Averna M R, Scafidi V, Galione A & Notarbartolo A (1992) Increased lipoprotein (a) levels in subjects with chronic renal failure on heamodialysis. Nephron 62, 471-472
59. Saviana B, Quilliot D, Ziegler O, Bigard M A, Drouin P & Gueant J L (1999) Diagnosis of lipid malabsorption in patients with chronic pancreatitis: A new indirect test using post prandial plasma apolipoprotein. B-48. Am J Gasteroentrol 11, 3229-3235
60. Rau B, Steinbach G, Baumgart K, Gansauge F, Grunert A & Beger H G (2000) Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value or an alternative acute-phase reactant. Crit Care Med 28, 736-742
61. Chang Y T, Tsai S F, Wang W J, Hong C J, Huang C Y & Wong C K (2001) A study of Apolipoprotein E and A-I in cutaneous amyloid. Br J Dermatol 145, 422-427
62. Durrington P N (1995) Lipoprotein (a). Baillieres Clin Endocrinol Metab 9, 773-795
63. Effrosini E P, Athanassios A & Athina K (1998) Apolipoprotein E4 allele as genetic risk factor for left ventricular failure in homozygous β thallasemia. Blood 92, 3455-3459
64. Louhija J, Miettinen H E, Kontula K, Tikkanen M J, Miettinen T A & Tilvis R S (1994) Aging and Genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscler Thromb 14, 1084-1089
65. Cooper M E, Akdeniz A & Hardy K J (1996) Effects of liver transplantation and resection on lipid parameters: a longitudinal study. Aust N Z J Surg 66, 743-746
66. Malmendier C L, Mailier E L, Amerijckx J P & Fischer M L (1983) Plasma levels of apolipoproteins A-I, A-II and B in alcoholism. Relation to the degree of histological liver damage, and to liver function tests. Hepatogastroenterology 30, 236-239
67. Floren C H & Gustafson A (1985) Apolipoproteins A-I, A-II and E in cholestatic liver disease. Scand J Clin Lab Invest 45, 103-108
68. Poynard T, Abella A, Pignon J P, Naveau S, Leluc R & Chaput J C (1986) Apolipoprotein AI and alcoholic liver disease. Hepatology 6, 1391-1395
69. Sari R A, Polat M F, Taysi S, Bakan E & Capoglu I (2002) Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus. Clin Rheumatol 21, 520-524
70. Formiga F, Meco J F, Pinto X, Jacob J, Moga I & Pujol R (2001) Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients. Lupus 10, 359-363
71. Magaro M, Altomonte L, Zoli A, Mirone L & Ruffini M P (1991) Serum lipid pattern and apolipoproteins (A1 and B100) in active rheumatoid arthritis. Z Rheumatol 50, 168-170
72. Yamada T, Ozawa T, Gejyo F, Okuda Y, Takasugi K, Hotta O & Itoh Y (1998) Decreased serum apolipoprotein AII/AI ratio in systemic amyloidosis. Ann Rheum Dis 57, 249-251